Viewing Study NCT06180733


Ignite Creation Date: 2025-12-25 @ 2:49 AM
Ignite Modification Date: 2026-01-08 @ 11:01 AM
Study NCT ID: NCT06180733
Status: RECRUITING
Last Update Posted: 2023-12-22
First Post: 2023-12-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neo-adjuvant Pembrolizumab as an Alternative Treatment for MMRd Uterine Cancer
Sponsor: University Medical Center Groningen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module